Thoratec Announces FDA Approval Of HeartMate II® Pocket Controller™ (via PR Newswire)PLEASANTON, Calif., May 17, 2013 /PRNewswire/ — Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it has received approval from the U.S. Food and Drug Administration (FDA)…
published: May 20, 2013 in: Approval/Clearance, Cardio